Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 1218421)

Published in Biochem J on May 15, 1997

Authors

E Canbay1, M Norman, E Kilic, V Goffin, I Zachary

Author Affiliations

1: Department of Medicine, University of Bristol, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, U.K.

Articles cited by this

Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 11.06

Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol (1992) 7.97

Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol (1994) 7.53

Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A (1990) 7.39

Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature (1992) 5.72

Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem (1981) 5.49

Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol (1995) 5.36

Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci U S A (1990) 5.25

Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A (1992) 5.06

Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem (1992) 4.33

Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol (1994) 4.11

Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol (1993) 3.64

Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res (1995) 3.38

Focal adhesion kinase and associated proteins. Curr Opin Cell Biol (1994) 3.06

Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell (1992) 2.92

Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol (1995) 2.83

Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate. J Biol Chem (1992) 2.28

Extracellular matrix and hormones transcriptionally regulate bovine beta-casein 5' sequences in stably transfected mouse mammary cells. Proc Natl Acad Sci U S A (1990) 2.25

Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med (1995) 2.17

Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J (1995) 2.00

Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J Biol Chem (1994) 1.94

Expression of focal adhesion kinase gene and invasive cancer. Lancet (1993) 1.93

Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation of the focal adhesion-associated protein paxillin in Swiss 3T3 cells. J Biol Chem (1993) 1.61

Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61

The prolactin/growth hormone receptor family. Endocr Rev (1991) 1.53

Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res (1980) 1.46

Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. J Biol Chem (1993) 1.46

Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem (1995) 1.39

Tyrosine phosphorylation of the focal adhesion kinase pp125FAK during development: relation to paxillin. J Cell Sci (1993) 1.36

Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol (1994) 1.33

Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO J (1994) 1.30

Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res (1995) 1.25

Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem (1995) 1.18

Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem (1994) 1.17

Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci U S A (1994) 1.14

Prolactin receptors in human breast cancer cells in long-term tissue culture. Cancer Res (1979) 1.06

Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res (1987) 1.04

Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem (1995) 1.03

Prolactin activates the interferon-regulated p91 transcription factor and the Jak2 kinase by tyrosine phosphorylation. Proc Natl Acad Sci U S A (1994) 1.03

The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol Endocrinol (1994) 1.01

Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J Biol Chem (1995) 0.96

Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J Biol Chem (1994) 0.93

Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Mol Endocrinol (1996) 0.92

Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology (1995) 0.92

Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem (1990) 0.88

Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. Cancer Res (1986) 0.87

Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone. Cancer Res (1984) 0.81

A new serum-free method of measuring growth factor activities for human breast cancer cells in culture. In Vitro Cell Dev Biol (1988) 0.79

The rabbit mammary gland prolactin receptor is tyrosine-phosphorylated in response to prolactin in vivo and in vitro. J Biol Chem (1995) 0.79

Articles by these authors

Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet (2000) 4.54

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev (1998) 3.82

Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem (1997) 2.07

Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals. Mol Microbiol (2001) 2.01

Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section. Acta Paediatr (2009) 1.95

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93

Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J (2001) 1.91

Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation. Nature (1991) 1.87

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut (1999) 1.77

Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther (2003) 1.74

Normative data for iliac bone histomorphometry in growing children. Bone (2000) 1.74

Intrathecal sufentanil, fentanyl, or placebo added to bupivacaine for cesarean section. Anesth Analg (1997) 1.74

Perinatal water intoxication due to excessive oral intake during labour. Acta Paediatr (2002) 1.71

Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation (2000) 1.58

Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest (2000) 1.54

Anal incontinence after vaginal delivery: a prospective study in primiparous women. Br J Obstet Gynaecol (1999) 1.52

The effect of pleural fluid content on the development of pleural thickness. Int J Tuberc Lung Dis (2002) 1.51

Nasal versus full face mask for noninvasive ventilation in chronic respiratory failure. Eur Respir J (2004) 1.47

Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. J Biol Chem (1993) 1.46

Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett (1997) 1.45

High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells. Proc Natl Acad Sci U S A (1985) 1.43

Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod (2000) 1.40

Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr (1997) 1.40

Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab (1999) 1.36

Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A (1999) 1.35

Bacteremia on an obstetric-gynecologic service. Am J Obstet Gynecol (1975) 1.31

Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol (1986) 1.30

Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr Res (2000) 1.25

Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res (1995) 1.25

Moderately preterm infants and determinants of length of hospital stay. Arch Dis Child Fetal Neonatal Ed (2009) 1.19

Protein kinase C activation enhances cAMP accumulation in Swiss 3T3 cells: inhibition by pertussis toxin. Proc Natl Acad Sci U S A (1987) 1.17

Anal sphincter tears at vaginal delivery: risk factors and clinical outcome of primary repair. Obstet Gynecol (1999) 1.17

Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab (1999) 1.16

The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis. Oncogene (2007) 1.15

Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci U S A (1998) 1.15

Spontaneous Pneumothorax and Subcutaneous Emphysema. Br Med J (1957) 1.14

Determination of pH or lactate in fetal scalp blood in management of intrapartum fetal distress: randomised controlled multicentre trial. BMJ (2008) 1.13

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. Ann Intern Med (1977) 1.12

Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin Cell Dev Biol (2005) 1.12

Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol (1998) 1.11

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Increased catecholamines and heart rate in children with low birth weight: perinatal contributions to sympathoadrenal overactivity. J Intern Med (2007) 1.09

Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. Biochem Biophys Res Commun (2000) 1.08

Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res (2000) 1.06

Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolution. J Mol Biol (1994) 1.06

Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics (2001) 1.05

Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution. Biochim Biophys Acta (1998) 1.04

Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04

Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer (2010) 1.04

Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03

Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem (1995) 1.03

Stress-induced cytokine responses and central adiposity in young women. Int J Obes (Lond) (2007) 1.02

Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience (2001) 1.02

Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas (1995) 1.02

Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology (1999) 1.01

The cost and advantages of establishing an age-sex register. J R Coll Gen Pract (1977) 0.98

Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration. Arch Neurol (1975) 0.98

Identification of a receptor for peptides of the bombesin family in Swiss 3T3 cells by affinity cross-linking. J Biol Chem (1987) 0.98

VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther (1997) 0.97

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene (2000) 0.97

Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97

Graded expression patterns of ephrin-As in the superior colliculus after lesion of the adult mouse optic nerve. Mech Dev (2001) 0.96

The burden of diabetes in North Carolina. N C Med J (1995) 0.96

Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-delta and by mobilization of intracellular Ca2+. Biochem J (2001) 0.95

Inhibition of bombesin-induced mitogenesis by pertussis toxin: dissociation from phospholipase C pathway. Biochem Biophys Res Commun (1987) 0.95

Breast inflammatory gigantomastia in a context of immune-mediated diseases. J Clin Endocrinol Metab (2005) 0.95

Lower skin capillary density, normal endothelial function and higher blood pressure in children born preterm. J Intern Med (2007) 0.95

Corneocyte desquamation. Int J Mol Med (2000) 0.94

Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine. Vet Microbiol (1987) 0.94

Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol (2001) 0.94

Prenatal diagnosis of alpha-1-antitrypsin deficiency by fetal blood sampling. Prenat Diagn (1987) 0.93

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene (2006) 0.93

A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc Natl Acad Sci U S A (1995) 0.93

Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology (1998) 0.92

Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92

Nitric oxide modulation of focal adhesions in endothelial cells. Am J Physiol (1999) 0.92

Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res (2007) 0.91

First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91

Is it necessary to suture all lacerations after a vaginal delivery? Birth (2000) 0.90

Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells. Biochem Biophys Res Commun (2001) 0.90

Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis (2001) 0.90

Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis (2001) 0.90

Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases. Cardiovasc Res (1999) 0.90

Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience (2011) 0.90

Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun (2001) 0.90

Apnea in patients with myelomeningocele. Pediatr Neurosurg (1992) 0.90

Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas (1998) 0.89

Being born too small, too early, or both: does it matter for risk of hypertension in the elderly? Am J Hypertens (2008) 0.89

Identification of cytoplasmic motifs required for short prolactin receptor internalization. J Biol Chem (1997) 0.89

Fine structure mapping of the human X-linked hypophosphatemic rickets gene locus. J Clin Endocrinol Metab (1994) 0.89

Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur Respir J (2001) 0.89

A new approach to arthrocentesis of the temporomandibular joint. Int J Oral Maxillofac Surg (2008) 0.89

Prolactin and human tumourogenesis. J Neuroendocrinol (2010) 0.89

Regional variations in skin perfusion and skin thickness may contribute to varying efficacy of topical, local anaesthetics in neonates. Paediatr Anaesth (1996) 0.88

Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathways. FEBS Lett (1998) 0.88

Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther (2008) 0.88

Bacterial production and purification of recombinant human prolactin. Biotechnol Appl Biochem (1990) 0.88